{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:55:17Z","timestamp":1795085717885,"version":"4.10.2"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"13","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA211098"],"award-info":[{"award-number":["R01CA211098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01HL143403"],"award-info":[{"award-number":["U01HL143403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA211098"],"award-info":[{"award-number":["R01CA211098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA124586"],"award-info":[{"award-number":["R01CA124586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA023168"],"award-info":[{"award-number":["P30 CA023168"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA211098"],"award-info":[{"award-number":["R01CA211098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01HL143403"],"award-info":[{"award-number":["U01HL143403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA211098"],"award-info":[{"award-number":["R01CA211098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA124586"],"award-info":[{"award-number":["R01CA124586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA023168"],"award-info":[{"award-number":["P30 CA023168"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is associated with robust activity of the coagulation system. To determine mechanisms by which clotting factors influence PDAC tumor progression, we generated and characterized C57Bl\/6-derived KPC (KRasG12D, TRP53R172H) cell lines. Tissue factor (TF) and protease-activated receptor-1 (PAR-1) were highly expressed in primary KPC pancreatic lesions and KPC cell lines similar to expression profiles observed in biopsies of patients with PDAC. In allograft studies, tumor growth and metastatic potential were significantly diminished by depletion of TF or Par-1 in cancer cells or by genetic or pharmacologic reduction of the coagulation zymogen prothrombin in mice. Notably, PAR-1\u2013deleted KPC cells (KPC-Par-1KO) failed to generate sizable tumors, a phenotype completely rescued by restoration of Par-1 expression. Expression profiling of KPC and KPC-Par-1KO cells indicated that thrombin\u2013PAR-1 signaling significantly altered immune regulation pathways. Accordingly, KPC-Par-1KO cells failed to form tumors in immune-competent mice but displayed robust tumor growth comparable to that observed with control KPC cells in immune-compromised NSG mice. Immune cell depletion studies indicated that CD8 T cells, but not CD4 cells or natural killer cells, mediated elimination of KPC-Par-1KO tumor cells in C57Bl\/6 mice. These results demonstrate that PDAC is driven by activation of the coagulation system through tumor cell\u2013derived TF, circulating prothrombin, and tumor cell\u2013derived PAR-1 and further indicate that one key mechanism of thrombin\/PAR-1\u2013mediated tumor growth is suppression of antitumor immunity in the tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>The tissue factor\u2013thrombin\u2013PAR-1 signaling axis in tumor cells promotes PDAC growth and disease progression with one key mechanism being suppression of antitumor immunity in the microenvironment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-18-3206","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T14:15:49Z","timestamp":1556806549000},"page":"3417-3430","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1\u2013Dependent Immune Evasion"],"prefix":"10.1158","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-2611","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"first","affiliation":[{"name":"1Department of Biological Science and the Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Stang","sequence":"additional","affiliation":[{"name":"2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-9278","authenticated-orcid":false,"given":"Patrick G.","family":"Schweickert","sequence":"additional","affiliation":[{"name":"1Department of Biological Science and the Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Lanman","sequence":"additional","affiliation":[{"name":"1Department of Biological Science and the Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin N.","family":"Paul","sequence":"additional","affiliation":[{"name":"1Department of Biological Science and the Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett P.","family":"Monia","sequence":"additional","affiliation":[{"name":"3Ionis Pharmaceuticals, Inc., Antisense Drug Discovery, Carlsbad, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey S.","family":"Revenko","sequence":"additional","affiliation":[{"name":"3Ionis Pharmaceuticals, Inc., Antisense Drug Discovery, Carlsbad, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Palumbo","sequence":"additional","affiliation":[{"name":"2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Mullins","sequence":"additional","affiliation":[{"name":"2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett D.","family":"Elzey","sequence":"additional","affiliation":[{"name":"4Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith M.","family":"Janssen","sequence":"additional","affiliation":[{"name":"5Division of Immunobiology, Cincinnati Children's Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-3714","authenticated-orcid":false,"given":"Stephen F.","family":"Konieczny","sequence":"additional","affiliation":[{"name":"1Department of Biological Science and the Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Flick","sequence":"additional","affiliation":[{"name":"2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"2022061706292791600_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022061706292791600_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2022061706292791600_bib3","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"2022061706292791600_bib4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdm284","article-title":"Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients","volume":"18","author":"Mandal\u00e0","year":"2007","journal-title":"Ann Oncol"},{"key":"2022061706292791600_bib5","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-06-2351","article-title":"Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer","volume":"13","author":"Khorana","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022061706292791600_bib6","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-04-0866","article-title":"Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma","volume":"11","author":"Nitori","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061706292791600_bib7","first-page":"135","article-title":"Genetic determinants of cancer coagulopathy, angiogenesis and disease progression","volume":"52","author":"Rak","year":"2006","journal-title":"Vnitr Lek"},{"key":"2022061706292791600_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2011-06-317685","article-title":"The relationship between tissue factor and cancer progression: insights from bench and bedside","volume":"119","author":"van den Berg","year":"2012","journal-title":"Blood"},{"key":"2022061706292791600_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2008-1079255","article-title":"Mechanisms linking tumor cell\u2013associated procoagulant function to tumor dissemination","volume":"34","author":"Palumbo","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"2022061706292791600_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bjs.1800820831","article-title":"Tissue factor expression correlates with histological grade in human pancreatic cancer","volume":"82","author":"Kakkar","year":"1995","journal-title":"Br J Surg"},{"key":"2022061706292791600_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopha.2003.11.007","article-title":"Antitumor and antimetastatic effect of warfarin and heparins","volume":"58","author":"Bobek","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"2022061706292791600_bib12","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1158\/0008-5472.CAN-15-0964","article-title":"Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen","volume":"75","author":"Adams","year":"2015","journal-title":"Cancer Res"},{"key":"2022061706292791600_bib13","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.21769\/BioProtoc.930","article-title":"Pancreatic acinar cell 3-dimensional culture","volume":"3","author":"Qu","year":"2013","journal-title":"Bio-protocol"},{"key":"2022061706292791600_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.2908","article-title":"Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing","volume":"32","author":"Tsai","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2022061706292791600_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061706292791600_bib16","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2008.12.066","article-title":"Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia","volume":"136","author":"Shi","year":"2009","journal-title":"Gastroenterology"},{"key":"2022061706292791600_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/blood-2008-07-169003","article-title":"Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain","volume":"113","author":"Mullins","year":"2009","journal-title":"Blood"},{"key":"2022061706292791600_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/nat.2015.0560","article-title":"Reversing antisense oligonucleotide activity with a sense oligonucleotide antidote: proof of concept targeting prothrombin","volume":"25","author":"Crosby","year":"2015","journal-title":"Nucleic Acid Ther"},{"key":"2022061706292791600_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1538-7836.2004.00545.x","article-title":"Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells","volume":"2","author":"Jiang","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2022061706292791600_bib20","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/ATVBAHA.108.177428","article-title":"Tissue factor and PAR2 signaling in the tumor microenvironment","volume":"29","author":"Schaffner","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022061706292791600_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr1871","article-title":"Tissue factor, angiogenesis and tumour progression","volume":"10","author":"Bluff","year":"2008","journal-title":"Breast Cancer Res"},{"key":"2022061706292791600_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm1037","article-title":"Regulation of angiogenesis by tissue factor cytoplasmic domain signaling","volume":"10","author":"Belting","year":"2004","journal-title":"Nat Med"},{"key":"2022061706292791600_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"key":"2022061706292791600_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1245\/s10434-015-4592-2","article-title":"Levels of alternatively spliced tissue factor in the plasma of patients with pancreatic cancer may help predict aggressive tumor phenotype","volume":"22","author":"Unruh","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2022061706292791600_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2008-1079256","article-title":"Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis","volume":"34","author":"Signaevsky","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"2022061706292791600_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ijc.28327","article-title":"Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma","volume":"134","author":"Unruh","year":"2014","journal-title":"Int J Cancer"},{"key":"2022061706292791600_bib27","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.28726","article-title":"Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance","volume":"135","author":"Queiroz","year":"2014","journal-title":"Int J Cancer"},{"key":"2022061706292791600_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156652412799218868","article-title":"Genomic sequencing of key genes in mouse pancreatic cancer cells","volume":"12","author":"Wang","year":"2012","journal-title":"Curr Mol Med"},{"key":"2022061706292791600_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2007-01-065995","article-title":"Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms","volume":"110","author":"Palumbo","year":"2007","journal-title":"Blood"},{"key":"2022061706292791600_bib30","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0049-3848(07)70135-4","article-title":"The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression","volume":"120","author":"Milsom","year":"2007","journal-title":"Thromb Res"},{"key":"2022061706292791600_bib31","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.89.24.11832","article-title":"Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis","volume":"89","author":"Mueller","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706292791600_bib32","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2011-03-341222","article-title":"Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain","volume":"118","author":"Horowitz","year":"2011","journal-title":"Blood"},{"key":"2022061706292791600_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"key":"2022061706292791600_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2008.02938.x","article-title":"Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function","volume":"6","author":"Palumbo","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2022061706292791600_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1158\/1541-7786.514.2.9","article-title":"Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation","volume":"2","author":"Darmoul","year":"2004","journal-title":"Mol Cancer Res"},{"key":"2022061706292791600_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/ejso.2001.1141","article-title":"Thrombin enhances adhesion in pancreatic cancer in vitro through the activation of the thrombin receptor PAR 1","volume":"27","author":"Rudroff","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"2022061706292791600_bib37","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1074\/jbc.M007027200","article-title":"Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin","volume":"276","author":"Even-Ram","year":"2001","journal-title":"J Biol Chem"},{"key":"2022061706292791600_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"2022061706292791600_bib39","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-08-0177","article-title":"Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer","volume":"7","author":"Agarwal","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2022061706292791600_bib40","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"2022061706292791600_bib41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J Immunother"},{"key":"2022061706292791600_bib42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"2022061706292791600_bib43","doi-asserted-by":"crossref","first-page":"13718","DOI":"10.1074\/jbc.274.19.13718","article-title":"Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of Gi-linked Ras\/mitogen-activated protein kinase pathway","volume":"274","author":"Ellis","year":"1999","journal-title":"J Biol Chem"},{"key":"2022061706292791600_bib44","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1038\/onc.2008.324","article-title":"p53 controls hPar1 function and expression","volume":"27","author":"Salah","year":"2008","journal-title":"Oncogene"},{"key":"2022061706292791600_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI61667","article-title":"PAR1 contributes to influenza A virus pathogenicity in mice","volume":"123","author":"Khoufache","year":"2013","journal-title":"J Clin Invest"},{"key":"2022061706292791600_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6793-7-4","article-title":"Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation","volume":"7","author":"Saban","year":"2007","journal-title":"BMC Physiol"},{"key":"2022061706292791600_bib47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.159.5.1295","article-title":"Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1\u20132+ effector T cells","volume":"159","author":"North","year":"1984","journal-title":"J Exp Med"},{"key":"2022061706292791600_bib48","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.194.11.1549","article-title":"Tumor rejection by disturbing tumor stroma cell interactions","volume":"194","author":"Ibe","year":"2001","journal-title":"J Exp Med"},{"key":"2022061706292791600_bib49","first-page":"1144","article-title":"A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor","volume":"297","author":"Hammond-McKibben","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"2022061706292791600_bib50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm.2376","article-title":"Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy","volume":"17","author":"Celli","year":"2011","journal-title":"Nat Med"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/13\/3417\/2783445\/3417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/13\/3417\/2783445\/3417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T14:57:23Z","timestamp":1655477843000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/79\/13\/3417\/638290\/Thrombin-Signaling-Promotes-Pancreatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-3206","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22421115","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22421112.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510846.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22421115.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510846","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22421112","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}